WallStreetZenWallStreetZen

NASDAQ: BTAI
Bioxcel Therapeutics Inc Earnings & Revenue

BTAI past revenue growth

How has BTAI's revenue growth performed historically?
Company
202.24%
Industry
83.05%
Market
15.22%
BTAI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BTAI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BTAI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BTAI earnings and revenue history

Current Revenue
$1.8M
Current Earnings
-$153.0M
Current Profit Margin
-8,715.7%

BTAI Return on Equity

Current Company
N/A
Current Industry
16.7%
Current Market
28.2%

Be the first to know when BTAI announces earnings.

BTAI Return on Assets

Current Company
-154.4%
Current Industry
3.2%
BTAI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BTAI Return on Capital Employed

Current Company
-274.37%
Current Industry
-43.6%
BTAI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BTAI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BTAI$1.76M-$139.18M-$153.05M+202.24%N/A
AFMD$8.99M-$114.03M-$115.15M-19.55%N/A
TLSA$0.00-$17.15M-$17.69MN/AN/A
ALRN$0.00-$17.93M-$18.07MN/AN/A
PASG$0.00-$80.89M-$84.44MN/AN/A

Bioxcel Therapeutics Earnings & Revenue FAQ

What were BTAI's earnings last quarter?

On Invalid Date, Bioxcel Therapeutics (NASDAQ: BTAI) reported Q1 2024 earnings per share (EPS) of -$0.87, up 52.72% year over year. Total Bioxcel Therapeutics earnings for the quarter were -$26.79 million. In the same quarter last year, Bioxcel Therapeutics's earnings per share (EPS) was -$1.84.

If you're new to stock investing, here's how to buy Bioxcel Therapeutics stock.

What was BTAI's earnings growth in the past year?

As of Q2 2024, Bioxcel Therapeutics's earnings has grown year over year. Bioxcel Therapeutics's earnings in the past year totalled -$153.05 million.

What was BTAI's revenue last quarter?

On Invalid Date, Bioxcel Therapeutics (NASDAQ: BTAI) reported Q1 2024 revenue of $582.00 thousand up 182.52% year over year. In the same quarter last year, Bioxcel Therapeutics's revenue was $206.00 thousand.

What was BTAI's revenue growth in the past year?

As of Q2 2024, Bioxcel Therapeutics's revenue has grown 202.24% year over year. This is 119.19 percentage points higher than the US Biotechnology industry revenue growth rate of 83.05%. Bioxcel Therapeutics's revenue in the past year totalled $1.76 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.